Literature DB >> 8342961

Mast cell tryptase and chymase in developing and mature psoriatic lesions.

I T Harvima1, A Naukkarinen, K Paukkonen, R J Harvima, M L Aalto, L B Schwartz, M Horsmanheimo.   

Abstract

The number and distribution of mast cells in non-lesional and lesional skin samples from 13 psoriatic patients were analyzed enzyme- and immunohistochemically. Mast cell tryptase was stained with the sensitive substrate Z-Gly-Pro-Arg-4-methoxy-2-naphthylamide, and chymase with Suc-Val-Pro-Phe-MNA and monoclonal B7 anti-chymase antibody. In addition, healthy-looking skin from 27 psoriatic patients was tape-stripped resulting in induction of the Köbner response in 9 patients. Sequential biopsies were taken before and after (7, 14 and 21 days) tape-stripping, and both tryptase and chymase were stained enzyme-histochemically. In non-lesional psoriatic skin, 70 +/- 24% (mean +/- SD) of the mast cells contained chymase enzyme activity, and 78 +/- 18% chymase immunoreactivity. About 10% of the chymase-immunoreactive cells lacked chymase activity. In lesional psoriatic skin, tryptase-positive cells were increased in number throughout the dermis but especially beneath the epidermis. Chymase immunoreactivity paralleled the tryptase activity, whereas chymase activity was strongly diminished both in terms of mast cell numbers and in staining intensity in the papillary dermis. The apparent inactivation of chymase may be due to the action of the chymase inhibitors, alpha 1-antitrypsin and alpha 1-antichymotrypsin, localized immunohistochemically in mast cells of lesional and non-lesional psoriatic skin. In the developing psoriatic lesion, mast cells displaying chymase activity were already 27-38% decreased in number in the upper dermis on day 7 after tape-stripping, along with the first clinical signs of psoriasis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342961     DOI: 10.1007/bf00372007

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  43 in total

1.  Ultrastructural analysis of maturing human T and TC mast cells in situ.

Authors:  S S Craig; N M Schechter; L B Schwartz
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

2.  Mast cells and macrophages in early relapsing psoriasis.

Authors:  C Schubert; E Christophers
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Biochemical and histochemical evaluation of tryptase in various human tissues.

Authors:  I T Harvima; K Karkola; R J Harvima; A Naukkarinen; H Neittaanmäki; M Horsmanheimo; J E Fräki
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.

Authors:  J C Powers; T Tanaka; J W Harper; Y Minematsu; L Barker; D Lincoln; K V Crumley; J E Fraki; N M Schechter; G G Lazarus
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

5.  Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.

Authors:  S Sayama; R V Iozzo; G S Lazarus; N M Schechter
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

6.  Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions.

Authors:  A Naukkarinen; I Harvima; K Paukkonen; M L Aalto; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Fibrous mastocytoma in a patient with generalized cutaneous mastocytosis.

Authors:  C Wood; B Sina; C G Webster; D Kurgansky; C B Drachenberg; E A Reedy
Journal:  J Cutan Pathol       Date:  1992-04       Impact factor: 1.587

8.  Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; J E Fräki
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

9.  Human skin tryptase: purification, partial characterization and comparison with human lung tryptase.

Authors:  I T Harvima; N M Schechter; R J Harvima; J E Fräki
Journal:  Biochim Biophys Acta       Date:  1988-11-02

10.  Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

View more
  14 in total

1.  Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate.

Authors:  G Nilsson; T Blom; I Harvima; M Kusche-Gullberg; K Nilsson; L Hellman
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells.

Authors:  K Hamann; J Grabbe; P Welker; N Haas; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.

Authors:  Andrew M Lin; Cory J Rubin; Ritika Khandpur; Jennifer Y Wang; MaryBeth Riblett; Srilakshmi Yalavarthi; Eneida C Villanueva; Parth Shah; Mariana J Kaplan; Allen T Bruce
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

4.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).

Authors:  Cristian Turato; Patrizia Pontisso
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2015

5.  Latexin, a carboxypeptidase A inhibitor, is expressed in rat peritoneal mast cells and is associated with granular structures distinct from secretory granules and lysosomes.

Authors:  Y Uratani; K Takiguchi-Hayashi; N Miyasaka; M Sato; M Jin; Y Arimatsu
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 6.  Mast cell proteinases and cytokines in skin inflammation.

Authors:  I T Harvima; L Horsmanheimo; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.

Authors:  M-M Suttle; G Nilsson; E Snellman; I T Harvima
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

8.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

Review 9.  The role of mast cells in human skin cancers.

Authors:  Domenico Ribatti; Roberto Tamma; Tiziana Annese; Enrico Crivellato
Journal:  Clin Exp Med       Date:  2021-02-12       Impact factor: 3.984

Review 10.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.